AI assistant
Hansa Biopharma Major Shareholding Notification 2021
3057_iss_2021-12-08_1e31df62-365e-45a4-99a9-cb020be9a9e6.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Hansa Biopharma AB
Holder
Handelsbanken Fonder AB
Instrument
| Instrument | Aktie SE0002148817 |
|---|---|
| Before the transaction | |
| Shares | 2,319,799 |
| Voting rights | 2,319,799 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 07/12/2021 |
| Limit for number of shares | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,266,350 |
| Directly held voting rights | 2,266,350 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.94 % |
| Directly held voting rights | 5.08 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.08 % | 2,266,350 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled - Cash settled |
||
| Total | 5.08 % | 2,266,350 |
| Group total holdings |
||
| Voting rights 2,266,350 |
||
| Percentage of voting rights 5.08 | ||
| Published | ||
| 08/12/2021 13:59 | ||
| Contact | ||
| Name Gustav Lindberg |
||
| Phone 087011417 |
Email [email protected] | |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25